Placebo, prozac and PLoS: significant lessons for psychopharmacology.
about
Fluoxetine versus other types of pharmacotherapy for depressionIs there an excess of significant findings in published studies of psychotherapy for depression?Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateLessons learned from placebo groups in antidepressant trialsSerotonin circuits and anxiety: what can invertebrates teach us?Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depressionAre antidepressants clinically useful? Conclusion of a decade of debate.Enhanced responsiveness to selective serotonin reuptake inhibitors during lactation.Solving the antidepressant efficacy question: effect sizes in major depressive disorderThe media and intellectuals' response to medical publications: the antidepressants' case.No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.Burning issues in the meta-analysis of pharmaceutical trials for depression.Serotonin and brain function: a tale of two receptorsThe public debate on psychotropic medication and changes in attitudes 1990-2011.Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology.The misleading concept of initial severity in depression clinical trials: development and results from a mathematical model.A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors.
P2860
Q24201165-FBE341FE-2458-4853-9896-3C799E0CD461Q26991727-75B283ED-AA6F-47AA-B13A-BECE21B07236Q27004490-11A2BC76-8675-47FC-A8EF-69C147B3120CQ28478927-8BDB0B50-F846-46AC-9712-CEFD138BB6D9Q28485318-2591B41D-C1A5-4870-B6BC-ED45145FF1B4Q28550946-1A317182-6D33-4545-BCE5-CC283FDB91F9Q33915538-E9755795-38D1-46B9-BAA4-444080981F54Q35092485-6F9F7D0A-9E6B-4FBC-B3CA-D73E8945B930Q35624327-F1AC3FC8-1419-402E-9BA3-3B860A282AFEQ36814806-E351B92E-080F-4A63-8343-5EA2ACA8BAFFQ37116846-57E4DB8F-94A7-4549-A587-8A8E7CEAD792Q38138536-6FD66AE0-8BD8-4D5C-AAF6-40C71112D797Q38600048-E7B0BA8F-BFDD-4535-BA08-2175E4F73C26Q38937714-5FE8D560-44EF-49DD-B1FE-74021EBA81B8Q39010517-CD1FC68E-EFDF-48BE-838A-37725A83BEB6Q39344538-5C20AC0E-5561-449F-9FA9-01FD416AC125Q39703632-1FA6821F-95F7-4BEF-B5DD-85B61090996E
P2860
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
@ast
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
@en
type
label
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
@ast
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
@en
prefLabel
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
@ast
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
@en
P2860
P356
P1476
Placebo, prozac and PLoS: significant lessons for psychopharmacology.
@en
P2093
Paul Matthews
Robert Waldmann
P2860
P304
P356
10.1177/0269881110372544
P407
P50
P577
2010-06-22T00:00:00Z